Piramal divests its DRG Business for $950 million
PEL had initially invested US$650 Million in 2012 to acquire DRG out of which $260 Mn was infused as equity
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Clarivate Analytics
India an emerging hub for biologics and biosimilars: Report
The report examines the transformation of the pharmaceutical/biotech industry from small molecule therapeutics to biotherapeutics…